[go: up one dir, main page]

SE0300535D0 - Treatment of burns - Google Patents

Treatment of burns

Info

Publication number
SE0300535D0
SE0300535D0 SE0300535A SE0300535A SE0300535D0 SE 0300535 D0 SE0300535 D0 SE 0300535D0 SE 0300535 A SE0300535 A SE 0300535A SE 0300535 A SE0300535 A SE 0300535A SE 0300535 D0 SE0300535 D0 SE 0300535D0
Authority
SE
Sweden
Prior art keywords
burns
treatment
topical
diclofenac
manufacture
Prior art date
Application number
SE0300535A
Other languages
English (en)
Other versions
SE0300535L (sv
SE527137C2 (sv
Inventor
Dominique Sallin
Jean-Luc Kienzler
Phyllis Schumann
Jacek Ancerewicz
Original Assignee
Novartis Consumer Health Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Consumer Health Sa filed Critical Novartis Consumer Health Sa
Publication of SE0300535D0 publication Critical patent/SE0300535D0/sv
Publication of SE0300535L publication Critical patent/SE0300535L/sv
Publication of SE527137C2 publication Critical patent/SE527137C2/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Semiconductor Lasers (AREA)
  • Polarising Elements (AREA)
  • Magnetic Heads (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE0300535A 2000-09-01 2003-02-28 Behandling av brännskador med ett diklofenaksalt SE527137C2 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00118968 2000-09-01
PCT/EP2001/010041 WO2002017905A2 (en) 2000-09-01 2001-08-30 Treatment of burns

Publications (3)

Publication Number Publication Date
SE0300535D0 true SE0300535D0 (sv) 2003-02-28
SE0300535L SE0300535L (sv) 2003-04-29
SE527137C2 SE527137C2 (sv) 2005-12-27

Family

ID=8169725

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0300535A SE527137C2 (sv) 2000-09-01 2003-02-28 Behandling av brännskador med ett diklofenaksalt

Country Status (31)

Country Link
US (1) US20030187069A1 (sv)
JP (1) JP2004507497A (sv)
KR (1) KR100880056B1 (sv)
CN (1) CN100350905C (sv)
AR (1) AR030522A1 (sv)
AT (1) AT504040B1 (sv)
AU (2) AU2001287706B2 (sv)
BE (1) BE1014352A5 (sv)
CA (1) CA2414921C (sv)
CH (1) CH695416A5 (sv)
CZ (1) CZ303849B6 (sv)
DE (2) DE10196483B4 (sv)
DK (1) DK200300274A (sv)
ES (1) ES2201941B1 (sv)
FI (1) FI119840B (sv)
FR (1) FR2813530B1 (sv)
GB (1) GB2381455B (sv)
GR (1) GR1004434B (sv)
HU (1) HU230783B1 (sv)
IL (2) IL153816A0 (sv)
IT (1) ITMI20011820A1 (sv)
LU (1) LU91009B1 (sv)
MX (1) MXPA03001830A (sv)
NL (1) NL1018862C2 (sv)
NO (1) NO330590B1 (sv)
PL (1) PL359807A1 (sv)
RU (1) RU2314802C2 (sv)
SE (1) SE527137C2 (sv)
TW (1) TWI290464B (sv)
WO (1) WO2002017905A2 (sv)
ZA (1) ZA200300284B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20040321A1 (es) 2002-08-22 2004-07-15 Novartis Consumer Health Sa Composicion topica que comprende diclofenaco
EP2055298A1 (en) * 2007-10-30 2009-05-06 Novartis AG Topical composition
CN105395544A (zh) * 2014-08-23 2016-03-16 南京海纳医药科技有限公司 双氯芬酸依泊胺凝胶制备方法及药物用途
AU2015313842A1 (en) 2014-09-10 2017-03-30 Novartis Consumer Health S.A. Topical diclofenac sodium compositions

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT370721B (de) 1981-02-24 1983-04-25 Ciba Geigy Ag Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der
DE8210781U1 (de) * 1982-04-16 1982-06-24 Unilever N.V., 3000 Rotterdam Staubdichte Faltschachtel
CH655656B (sv) * 1982-10-07 1986-05-15
JPS59170011A (ja) * 1983-03-16 1984-09-26 Pola Chem Ind Inc 日焼け防止化粧料
DE3707532C2 (de) 1987-03-09 1998-05-28 Bauer Johann Verwendung einer Kombination von Extr. Gingko biloba oder mindestens einem Gingkolid und Acetylsalicylsäure oder DL-Lysin-mono-acetylsalicylat oder Diflunisal zur Behandlung von Verbrennungen, Verbrühungen, Strahlenschäden und Erfrierungen
US4847071A (en) 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent
IT1229489B (it) 1988-12-09 1991-09-03 Altergon Sa Composizioni farmaceutiche lipidiche per uso topico atte a veicolare un principio attivo antiinfiammatorio idrosolubile
RU2008002C1 (ru) * 1989-03-23 1994-02-28 Центр по химии лекарственных средств Противовоспалительный состав и способ его получения
US5674912A (en) * 1991-03-01 1997-10-07 Warner-Lambert Company Sunscreen-wound healing compositions and methods for preparing and using same
JP3526887B2 (ja) 1993-04-23 2004-05-17 帝國製薬株式会社 消炎鎮痛外用貼付剤
ATE334689T1 (de) * 1995-11-13 2006-08-15 Univ Northwest Verabreichungsmedium für analgetische, entzündungshemmende und antipyretische wirkstoffe und pharmazeutische zusammensetzungen enthaltend solches medium und wirkstoffe
JP4181232B2 (ja) * 1997-07-18 2008-11-12 帝國製薬株式会社 ジクロフェナクナトリウム含有油性外用貼付製剤
KR19990026792A (ko) * 1997-09-26 1999-04-15 김윤 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제
EP0923937B1 (en) * 1997-12-08 2004-03-10 Council of Scientific and Industrial Research A herbal formulation useful as a therapeutic and cosmetic application for the treatment of general skin disorders
DE19844116A1 (de) 1998-08-06 2000-02-24 Vascular Biotech Gmbh Wirkstoffkombination insbesondere zur Prophylaxe und Therapie von ischämischen Organschäden und Reperfusionssyndromen
RU2140258C1 (ru) * 1999-03-17 1999-10-27 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Гидрофильная фармацевтическая композиция, обладающая противовоспалительным действием
AU5460800A (en) * 1999-06-02 2000-12-18 Aviana Biopharm Pharmaceutical transdermal compositions
US6368618B1 (en) * 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
DE10025328A1 (de) * 2000-05-23 2001-12-06 Lohmann Therapie Syst Lts Acetylsalicylsäure enthaltendes superfizielles therapeutisches System zur Behandlung von Hautschmerzen

Also Published As

Publication number Publication date
KR100880056B1 (ko) 2009-01-22
WO2002017905A3 (en) 2002-05-16
SE0300535L (sv) 2003-04-29
ITMI20011820A1 (it) 2003-02-28
LU91009B1 (de) 2003-02-19
GR20010100390A (el) 2002-07-31
FR2813530B1 (fr) 2005-05-20
CH695416A5 (de) 2006-05-15
HUP0300876A3 (en) 2009-08-28
DK200300274A (da) 2003-02-24
HK1056828A1 (en) 2004-03-05
GR1004434B (el) 2004-02-03
AR030522A1 (es) 2003-08-20
HUP0300876A2 (hu) 2003-10-28
CN1449282A (zh) 2003-10-15
CZ2003574A3 (cs) 2003-06-18
CA2414921A1 (en) 2002-03-07
HU230783B1 (hu) 2018-05-02
NO20030767D0 (no) 2003-02-18
KR20030027100A (ko) 2003-04-03
CN100350905C (zh) 2007-11-28
JP2004507497A (ja) 2004-03-11
SE527137C2 (sv) 2005-12-27
AU8770601A (en) 2002-03-13
IE20010782A1 (en) 2003-04-16
DE10196483B4 (de) 2023-08-24
DE10196483T1 (de) 2003-07-31
MXPA03001830A (es) 2004-11-01
GB0304150D0 (en) 2003-03-26
AT504040B1 (de) 2008-07-15
RU2314802C2 (ru) 2008-01-20
PL359807A1 (en) 2004-09-06
CA2414921C (en) 2010-02-09
IL153816A (en) 2011-07-31
ITMI20011820A0 (it) 2001-08-28
ES2201941B1 (es) 2005-06-01
FI20030276A7 (sv) 2003-02-25
CZ303849B6 (cs) 2013-05-29
NO330590B1 (no) 2011-05-23
NL1018862C2 (nl) 2002-03-05
IL153816A0 (en) 2003-07-31
ZA200300284B (en) 2004-03-10
ES2201941A1 (es) 2004-03-16
US20030187069A1 (en) 2003-10-02
GB2381455A (en) 2003-05-07
WO2002017905A2 (en) 2002-03-07
FR2813530A1 (fr) 2002-03-08
AT504040A1 (de) 2008-02-15
FI119840B (sv) 2009-04-15
AU2001287706B2 (en) 2005-04-07
TWI290464B (en) 2007-12-01
GB2381455B (en) 2004-06-30
NO20030767L (no) 2003-02-18
BE1014352A5 (fr) 2003-09-02

Similar Documents

Publication Publication Date Title
EE200400020A (et) Asendatud oksasolidinoonid kombineeritud raviks
DE50310516D1 (de) Fredericamycin-derivate
CY1105082T1 (el) Χρηση της φλιβανσepινης στην αγωγη διαταραχων της σεξουαλικης επιθυμιας
HN2001000244A (es) Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas.
AR032293A1 (es) Estuche farmaceutico
SE0101932D0 (sv) Pharmaceutical combinations
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
DE60142913D1 (de) Arzneilösungen enthaltend modafinilverbindungen
SE0102440D0 (sv) New compound
ATE360428T1 (de) Analgetisches arzneimittel
PT1150704E (pt) Melagatran para o tratamento da inflamacao
CY1105142T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
SE0004101D0 (sv) New use
SE0300535D0 (sv) Treatment of burns
SE0000303D0 (sv) Novel compounds
MXPA03003980A (es) Uso de melagatran para la elaboracion de un medicamento para el tratamiento de transtornos isquemicos.
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
TR199901206T2 (xx) Diyabetik damar rahats�zl�klar�n�n �nlenmesi i�in bir ila� �retiminde katekol-O-metil transferaz inhibit�rlerinin kullan�lmas�.
DK1399143T3 (da) Anvendelsen af Acetyl L-carnitin til fremstilling af et lægemiddel til behandling af anhedoni
SE0101762D0 (sv) New use
UA38786A (uk) Фібринолітичний засіб